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Epidermal Growth Factor Receptor Activation
Ulf Meyer-Hoffert, Jana Wingertszahn, and Oliver Wiedow
Department of Dermatology, University Kiel, Kiel, Germany
Epidermal hyperproliferation and neutrophil inﬁltration are major histopathological changes observed in psoriasis.
Neutrophils contain human leukocyte elastase (HLE), which is released at sites of inﬂammation. HLE is present in
psoriatic lesions and induces keratinocyte hyperproliferation in vitro and in vivo. To determine the molecular
mechanisms linking a proteolytic effect of HLE and epidermal hyperproliferation, we examined the effects of HLE-
induced signaling in human keratinocytes. Application of 100 nM HLE resulted in a transient calcium inﬂux in
FURA2-loaded human HaCaT keratinocytes observed by single-cell ﬂuorescence imaging. The calcium signal was
concentration dependent and was inhibited by addition of the HLE inhibitors elaﬁn and secretory leukocyte
protease inhibitor. The calcium signal was neither inhibited by pertussis toxin, cholera, or by pre-stimulation with
trypsin. Incubation with the tyrosine kinase inhibitor genistein, a protein kinase C inhibitor, as well as incubation
with neutralizing EGFR antibodies abolished the HLE-induced calcium inﬂux. The supernatants of HLE-treated
keratinocytes induced a calcium signal in separately cultured keratinocytes. This could be inhibited by the addition
of anti-TGF-a antibodies. Application of HLE-induced keratinocyte proliferation, which could be inhibited by
neutralizing of anti-EGFR and anti-TGF-a antibodies. Herein we demonstrate that HLE induces keratinocyte
proliferation by proteolytic activation of an EGFR signaling cascade involving TGF-a.
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Psoriasis is morphologically characterized by epidermal
hyperproliferation and neutrophil infiltration in the epider-
mis. Neutrophils store the serine-protease human leukocyte
elastase (HLE) in their azurophile granules, which is released
at sites of inflammation. Active HLE is detectable on the
surface of psoriatic lesions, correlates well with skin
induration (Wiedow et al, 1992) and disappears with
successful therapy (Wiedow et al, 1995). In a previous
study, we were able to demonstrate that HLE induces
keratinocyte proliferation in vivo and in vitro by its proteo-
lytic activity. However, the mechanism of HLE-induced
keratinocyte proliferation remained unknown.
The induction of cellular proliferation by proteases may
occur by different principles. Some serine proteases are
known to activate a group of seven-transmembrane
receptors called protease-activated receptors (PAR). Fol-
lowing proteolysis, a new N-terminus of the extracellular
position of the receptor occurs, which acts as a tethered
ligand to activate a G-protein-coupled signaling pathway
including intracellular calcium as a second messenger (for a
review see Dery et al, 1998). There are four known members
of this receptor family: PAR1, PAR3, and PAR4, which are
cleaved and activated by thrombin, and PAR2, a receptor
for trypsin-like enzymes. Activation of PAR by specific
proteases regulates multiple cellular functions. For exam-
ple, agonists of PAR1 and PAR2 stimulate mitogen-
activated protein kinases and regulate cellular growth and
proliferation (Belham et al, 1996; Yu et al, 1997). Both
receptors have been described to be expressed in
keratinocytes and affect keratinocyte proliferation (Derian
et al, 1997). However, none of the four receptors is known to
be activated by HLE.
Some proteases, mainly metallo-proteinases, are known
to shed membrane-bound precursor molecules, which
subsequently act as soluble ligands to their corresponding
receptors. For example, the activation of the receptor
tyrosine-kinase ‘‘epidermal growth factor receptor’’ (EGFR),
also known as ErbB1, induces keratinocyte proliferation by
ligands of the epidermal growth factor family, which are
activated by cleavage of proteases (for reviews see King
et al, 1990; Schlessinger, 2000). The signaling pathway of
EGFR activation includes the rise in intracellular calcium
(Honegger et al, 1987). Transforming growth factor a (TGF-
a) represents such an EGFR ligand expressed in human
keratinocytes (Coffey, et al, 1987; Harris et al, 2003). TGF-a
is initially synthesized as a precursor, pro-TGF-a (Derynck
et al, 1984). The precursor is processed by an elastase-like
membrane-bound enzyme to its soluble form (Teixido et al,
1990; Cappelluti et al, 1993).
We hypothesized that HLE induces keratinocyte prolif-
eration by receptor activation, e.g. by PAR activation or
Abbreviations: BrdU, 5-bromo-20-deoxy-uridine; DMEM, Dulbec-
co’s modified Eagle’s medium; EGFR, epidermal growth factor
receptor; HLE, human leukocyte elastase; PAR, protease-activated
receptor; TGF-a, transforming growth factor a
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EGFR activation. Because both signaling pathways include
the transient rise in intracellular calcium we used changes of
the intracellular calcium levels as a readout system to
investigate the mechanism of HLE-induced keratinocyte
activation and proliferation.
Results
HLE induces calcium inﬂux in keratinocytes by its
proteolytic activity When HaCaT cells were incubated
with 100 nM HLE a transient increase in [Ca2þ ]i was
observed approximately 9 min after addition of HLE (90%–
100% cells per hpf responding) lasting for approximately
30 min (Fig 1A). Increased concentrations of 900 nM HLE
resulted in an earlier (3 min) calcium signal (Fig 1B), whereas
a concentration of 50 nM HLE lead to a later (18 min) and
less pronounced increase of [Ca2þ ]i (Fig 1C). The effect of
HLE-induced [Ca2þ ]i was abolished by incubating 100 nM
HLE together with 1 mM of the keratinocyte-derived HLE-
inhibitors elafin (Fig 1D) and secretory leukocyte protease
inhibitor (SLPI) (Fig 1E). Inhibition of proteolytic activity was
controlled by the lack of MeO-Suc-Ala-Ala-Pro-Val-p-
nitroalanilide-hydrolyzing activity.
The HLE-induced calcium signal is independent of PAR
activation Since it is known that some serine proteases are
capable of activating a group of G-protein-coupled recep-
tors called PAR, we investigated the HLE-induced [Ca2þ ]i
by PAR activation. The trypsin-induced increase of [Ca2þ ]i,
which is known to be mediated by activation of PAR1 and
PAR2, exhibited a different time kinetics in HaCaT kerati-
nocytes as compared with the HLE-induced [Ca2þ ]i (Fig
2A). The raise of [Ca2þ ]i was earlier (5–30 s after incubation)
and lasted for 5 min. In subsequent stimulations of HaCaT
cells, the HLE-induced [Ca2þ ]i was not inactivated by
pre-stimulation with 100 nM trypsin (Fig 2B). Neither pre-
incubation with pertussis toxin (1 mg per mL) nor pre-
incubation with cholera-toxin (1 mg per mL) to block G-
protein-coupled receptors abolished the HLE-induced
[Ca2þ ]i in keratinocytes, whereas both toxins inhibited
signaling by PAR as tested with specific activating peptides
(Fig 2C–F).
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Figure 1
Human leukocyte elastase (HLE) induces
calcium influx in keratinocytes by its pro-
teolytic activity. FURA-loaded HaCaT kerati-
nocytes were incubated with HLE in various
concentrations and fluorescence was mea-
sured at 340 and 380 nm by a video imaging
system for 1500 s every 3 s. The ratio was
calculated and pseudo-color images were
analyzed. Four exemplary images at different
time points are shown in (A). The brighter the
cells, the higher the ratio, 340/380 nm, which
correlates with the intracellular calcium level
[Ca2þ ]i. The graph in (A) demonstrates the
intracellular calcium level of a representative
single cell over the indicated time period after
adding 100 nM HLE. The kinetic while incubat-
ing keratinocytes with (B) 900 nM HLE, (C) with
50 nM HLE. Applying 100 nM HLE together
with its inhibitor 1 mM elafin (D) or 1 mM SLPI (E)
abolished the HLE-induced increase in [Ca2þ ]i.
(A) n¼ 25, (B–E) n¼4.
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HLE induces calcium inﬂux in keratinocytes by activat-
ing EGFR Because the family of growth factor receptors
is known to induce a transient increase of [Ca2þ ]i by a
tyrosine-kinase-dependent pathway in keratinocytes the
effect of the specific tyrosine kinase inhibitor genistein
on HLE-induced calcium signaling was examined. Pre-
incubation of HaCaT keratinocytes with 100 mM genistein
abolished the elastase-induced [Ca2þ ]i (90%–100% cells
Figure 2
The human leukocyte elastase (HLE)-induced calcium
signal is independent from protease-activated receptor
(PAR) activation. Application of trypsin (100 nM) resulted
in an immediate increase of [Ca2þ ]i in FURA2-loaded
HaCaT keratinocytes in contrast to HLE (100 nM), which
induced an increase in [Ca2þ ]i after approximately 9 min
(A). In subsequent stimulations, HLE induced calcium
signaling after trypsin incubation (B). HLE-mediated cal-
cium signaling was in contrast to PAR2-induced signaling,
neither inhibited by 60 min pre-incubation with 1 mg per mL
pertussis toxin (C,D) nor 1 mg per mL cholera toxin (E,F).
PAR2 was activated by 30 mM SFLLRN. Graphs show the
ratio of 340/380 nm of representative cells. Experiments
were repeated four times.
Figure 3
Human leukocyte elastase (HLE) induces calcium influx
in keratinocytes by activating epidermal growth factor
receptor (EGFR). Pre-incubation of FURA2-loaded HaCaT
keratinocytes with the tyrosine kinase inhibitor genistein
(100 mM; (A)) and the protein kinase C (50 mM) inhibitor
myristolylated EGFR fragment (B) inhibited a calcium signal
in subsequent HLE stimulation. Application of EGFR
antibodies abolished the HLE-induced increase of [Ca2þ ]i
in FURA2-loaded cells (C) as compared with HLE alone (D).
Graphs show the ratio of 340/380 nm of representative
cells. Experiments were repeated five times.
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per hpf, Fig 3A). The protein kinase C inhibitor myristoylated
EGFR fragment (50 mM, 60 min incubation) also inhibited
HLE-induced calcium signaling (Fig 3B). As the EGFR is
expressed in keratinocytes and HaCaT cells (Game et al,
1992) and can be inhibited by genistein, we hypothesized
that HLE activates EGFR to induce [Ca2þ ]i. Therefore, a
specific neutralizing EGFR antibody (5 mg per mL) was
added to the cells 10 min before incubation with 100 nM
HLE and maintained in the medium during the 30-min
stimulation, which prevented HLE-induced [Ca2þ ]i comple-
tely (Fig 3C). HLE was not inhibited by the antibody as
observed by MeO-Suc-Ala-Ala-Pro-Val-p-nitroalanilide hy-
drolyzis after the 30-min stimulation.
HLE releases TGF-a to activate EGFR To verify whether
HLE cleaves a membrane-bound precursor and releases
the EGFR activating molecule the supernatant of HaCaT
keratinocytes incubated with 100 nM HLE was collected
after 30 min. Neutralizing anti-EGFR antibodies (1 mg per
mL) were added 30 min before the HLE incubation to avoid
binding to EGFR of postulated ligands. The HLE-treated cell
culture supernatant was subsequently incubated with elafin
(1 mM) in further experiments to inhibit the proteolytic
activity of HLE (Fig 4A). This supernatant was transferred to
separately grown keratinocytes that resulted in an increase
of [Ca2þ ]i in 90%–100% of these cells per hpf (Fig 4B). The
calcium influx could be inhibited by pre-incubation of the
separately grown keratinocytes with neutralizing anti-EGFR
antibodies (data not shown) indicating that the stimulus for
EGFR activation is released into the cell culture supernatant
by HLE. The kinetic of the signal was similar to that
observed by TGF-a (40 ng per mL) to activate EGFR (Fig
4C). As it is known that pro-TGF-a is cleaved by elastase-
like enzymes a TGF-a blocking antibody (5 mg per mL) was
added to the cell culture supernatant after HLE treatment.
After 20 min incubation, the supernatant was transferred to
separately grown keratinocytes resulting in an inhibition
of the [Ca2þ ]i (80%–95% inhibition of responding cells,
Fig 4D). Pre-incubating keratinocytes with TGF-a antibodies
(5 mg per mL) resulted in an almost complete inhibition of
[Ca2þ ]i increase by 100 nM HLE (Fig 4E).
HLE induces EGFR activation in primary keratinocy-
tes The same kind of experiments were performed in
primary grown keratinocytes. Stimulation with 100 nM HLE
induced also a calcium signal in primary keratinocytes (Fig
5A). Addition of the elastase inhibitors SLPI and elafin
inhibited HLE-induced calcium signaling (Fig 5B). The
protein kinase C inhibitor myristoylated EGFR fragment
(50 mM, 1 h pre-incubation) also inhibited HLE-induced
calcium signaling (Fig 5C). Addition of an anti-EGFR
antibody 10 min prior to stimulation inhibited HLE-induced
Figure 4
Human leukocyte elastase (HLE) releases transforming
growth factor a (TGF-a) to activate epidermal growth
factor receptor (EGFR). The cell culture supernatant of
HLE-incubated keratinocytes, which were pre-incubated
with EGFR antibodies (1 mg per mL), was collected after
30 min stimulation. The cell culture supernatant was sub-
sequently incubated with elafin (1 mM) to inhibit the
proteolytical activity of HLE in subsequent stimulations of
FURA2-loaded HaCaT keratinocytes, indicated as ‘‘super-
natant’’ (A). The cell culture supernatant of HLE-incubated
cells induced calcium signaling in separately cultured cells
(B), which was similar to those observed by stimulating
HaCaT keratinocytes with 40 ng per mL TGF-a (C). Pre-
incubation of cells with 5 mg per mL TGF-a antibody
inhibited calcium signaling induced by the supernatant of
HLE-incubated cell (D) and direct HLE incubation (E).
Graphs show the ratio of 340/380 nm of representative
cells. Experiments were repeated four times.
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signaling (Fig 5D). In contrast to HaCaT cells, 10 mg instead
of 5 mg antibody per mL were needed to block HLE-induced
calcium signaling completely. Pre-incubation with TGF-a
antibodies (7.5 mg per mL) blocked the HLE-induced
calcium signaling in subsequent stimulations (Fig 5E).
HLE induces keratinocyte proliferation by EGFR acti-
vation To examine whether HLE induces keratinocyte
proliferation by EGFR activation and whether TGF-a
contributes to this activation the proliferation of HaCaT
keratinocytes was measured by 5-bromo-20-deoxy-uridine
(BrdU) incorporation in the presence of blocking EGFR and
TGF-a antibodies (both 5 mg per mL). HLE-induced HaCaT
proliferation in a concentration-dependent manner. Neutra-
lizing EGFR and TGF-a antibodies inhibited HLE-induced
hyperproliferation (Fig 6). The increase of proliferation with
33 nM HLE was in the same range as incubation with 40 ng
per mL EGF. A concentration of more than 33 nM HLE
resulted in a detachment of keratinocytes during the
experiment.
Discussion
Neutrophil infiltration of the epidermis and epidermal
hyperplasia are hallmarks of psoriasis and the neutrophil
serine protease elastase has been shown to be present in
psoriatic lesions (Wiedow et al, 1995). HLE induces
keratinocyte proliferation in vivo and in vitro (Rogalski
et al, 2002). Topical application of HLE on viable murine
skin-induced epidermal hyperproliferation, which was
dependent on the proteolytic activity. Histological analysis
revealed marked vasodilatation but no inflammatory infil-
trate. This points towards a direct proliferative effect of HLE
on keratinocytes. We hypothesized that HLE activates a
membrane receptor by proteolytic activation, as it is known
for the group of G-protein-coupled receptor PAR or by
cleaving a membrane bound precursor, which subsequently
activates a cell surface receptor, as it has been described
for the group of receptor tyrosine kinases. We speculated
that the activation of this proposed receptor induces a
signaling pathway, which includes [Ca2þ ]i as a second
messenger, leading to the induction of keratinocyte pro-
liferation.
In this study, we demonstrated that HLE induces a
transient increase of [Ca2þ ]i in human keratinocytes using a
single cell fluorescence video imaging system. The [Ca2þ ]i
increasing activity depended on the proteolytic activity of
HLE as we observed by application HLE together with a
10-fold molar excess of the HLE-inhibitor elafin. The calcium
influx was dependent on HLE concentration regarding the
time course and intensity of the [Ca2þ ]i increase.
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Figure 5
Human leukocyte elastase (HLE) induces epidermal
growth factor receptor (EGFR) activation in primary
keratinocytes. Stimulation with 100 nM HLE induced a
calcium signal in FURA-loaded primary keratinocytes (A).
Addition of 1 mM elafin (B), 50 mM myristoylated EGFR
fragment (C), 10 mg per mL anti-EGFR antibody (D) and
7.5 mg per mL TGF-a antibody (E) abolished the calcium
signaling in primary keratinocytes. Graphs show the ratio of
340/380 nm of representative cells. Experiments were
repeated three times.
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The HLE-induced signal was neither inhibited by pre-
incubation with pertussis toxin nor cholera toxin, two potent
inhibitors of G-protein signaling. Both toxins inhibited activa-
tion of PAR-dependent calcium increase. Stimulation with
trypsin activates PAR2 and to a lesser extent PAR1 and
inactivates PAR1 and PAR2 for subsequent trypsin-induced
calcium influx. However, after trypsin stimulation a subse-
quent incubation with HLE induced an increase in [Ca2þ ]i. We
conclude from these results that the HLE-induced increase in
[Ca2þ ]i is not mediated by activation of PAR. Moreover, it has
been reported that HLE inactivates PAR1, PAR2 (Loew et al,
2000), and PAR3 (Cumashi et al, 2001). Our investigations
make it unlikely that other PAR are expressed in keratinocytes
that are activated by HLE, since inhibition of G-protein
signaling did not influence the HLE-mediated calcium influx.
Pre-incubating keratinocytes with the selective tyrosine
kinase inhibitor genistein resulted in an inhibition of the HLE-
induced increase of [Ca2þ ]i. As the EGFR belongs to the
family of receptor tyrosine kinases and induces keratinocyte
proliferation after stimulation, we speculated that EGFR
might be involved in the HLE-induced increase of [Ca2þ ]i. In
this study, the HLE-induced increase of [Ca2þ ]i was
prevented by pre-incubation with a neutralizing EGFR
antibody, which is known to bind to the extracellular domain
of the EGFR and to inhibit ligand binding to EGFR
(Kawamoto et al, 1983; Gill et al, 1984). These results
indicate that ligand-dependent EGFR activation contributes
to the HLE-induced increase of [Ca2þ ]i.
The EGFR ligand TGF-a is known to be present on the
surface of human keratinocytes and HaCaT keratinocytes
(Game et al, 1992). Furthermore, TGF-a is reported to
induce keratinocyte proliferation (Coffey et al, 1987). It is
synthesized as a 160 amino acid membrane-bound
precursor, pro-TGF-a (Lee et al, 1995), which is cleaved at
Ala89-Val90 (Derynck et al, 1984) by elastase-like enzymes
(Teixido et al, 1990; Cappelluti et al, 1993). Soluble TGF-a is
a more potent EGFR ligand than the membrane-bound pro-
TGF-a (Brachmann et al, 1989) and binds to EGFR on the
same or adjacent cells (Pandiella and Massague, 1991). The
elastase-like enzymes that cleave pro-TGF-a may be
produced by the TGF-a expressing cells (Teixido et al,
1990; Cappelluti et al, 1993). In cultured fibroblasts HLE has
been reported to release soluble TGF-a (Mueller et al, 1990).
Kohri et al (2002) demonstrated the cleavage of TGF-a and
subsequent induction of mucin production in a pulmonary
mucoepidermoid carcinoma cell line by HLE. In this study,
the addition of TGF-a antibodies diminished the [Ca2þ ]i-
increasing activity in the cell culture of HLE-pre-stimulated
keratinocytes and inhibited the HLE-induced proliferation in
keratinocytes. Transferring the supernatant from HLE-
stimulated cells in the presence of the HLE-inhibitor elafin
resulted in an increase of [Ca2þ ]i in separately cultured
keratinocytes. Neutralizing antibodies against EGFR as well
as TGF-a inhibited the signal. These results indicate that
TGF-a is cleaved by proteolyticaly active HLE, becomes
soluble and subsequently activates EGFR to induce
proliferation in keratinocytes. TGF-a mRNA expression
was found to be increased in psoriasis (Elder et al, 1989).
It is conceivable that the upregulated pro-TGF-a is cleaved
by the HLE from infiltrating neutrophils and contributes to
the epidermal hyperproliferation in psoriasis. In a recent
study, it was demonstrated that supplementing TGF-a to
HaCaT grown in organotypic co-cultures normalized epi-
dermal tissue regeneration and induced HaCaT cell pro-
liferation (Maas-Szabowski et al, 2003). The increase of
BrdU-labeled proliferative keratinocytes was within the
same range as observed in this study. HaCaT cells have
been reported to express TGF-a as well as EGFR (Game et
al, 1992, Maas-Szabowski et al, 2003), though soluble TGF-
a concentrations in culture supernatants of HaCaT cells are
approximately 10 times lower compared with primary
keratinocytes. In our studies, two times higher concentra-
tions of EGFR antibody and a one and a half higher
concentration of TGF-a antibody were needed in primary
keratinocytes compared with HaCaT cells, which confirms
indirectly the different expression levels.
Keratinocytes produce several other growth factors
besides TGF-a. From the members of the EGFR ligands
TGF-a, amphiregulin, epiregulin, betacellulin, epigen, and
heparin-binding EGF are produced and secreted by
keratinocytes (Coffey, et al, 1987; Cook et al, 1991;
Hashimoto et al, 1994; Dlugosz et al, 1995; Shirakata
et al, 2000; Strachan et al, 2001). Cleavage of these EGFR
ligands by HLE has not been reported so far to the best of
our knowledge. In our study neutralizing antibodies against
TGF-a did not inhibit the increase in [Ca2þ ]i completely
Figure 6
Human leukocyte elastase (HLE) induces keratinocyte
proliferation by epidermal growth factor receptor
(EGFR) activation. Proliferation was measured by incor-
poration of bromodeoxy-uridine in the HaCaT keratinocyte
using a cell proliferating enzyme-linked immunosorbent
assay. Cells were treated with HLE (3–33 nM) for 20 h.
Concentration of more than 33 nM resulted in detachment
of cells. Increase of proliferation depended on EGFR
activation as demonstrated by adding HLE (33 nM)
together with 5 mg per mL EGFR antibodies. The HLE-
induced proliferation was also inhibited by the addition of
5 mg per mL TGF-a antibody. EGF was used as a positive
control to induce keratinocyte proliferation. Values are
means  SD of eight separate experiments carried out
three times. Significant difference compared with medium
control: #po0.001.
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(80%–95% inhibition of cells per hpf) when transferring the
cell culture supernatant from HLE-treated keratinocytes to
separately cultured cells. The other EGFR ligands may
contribute to this activation. However, in the here-presented
keratinocyte proliferation studies blocking TGF-a inhibited
the increase in cell proliferation to normal levels implicating
TGF-a might be the most important ligand for HLE-induced
EGFR activation. The highest increase in keratinocyte
proliferation by HLE was in the same range as the one
observed by EGF stimulation supporting our conclusion that
HLE-induced keratinocyte proliferation is predominantly
mediated by EGFR activation.
The concentrations of HLE, which were tested on
cultured keratinocytes in this study, are comparable with
those found on the skin surface of psoriatic lesions (Wiedow
et al, 1995). Measuring the skin surface proteolytic activity
of HLE on psoriatic lesions, the 95% confidence interval
was between 5 and 50 fmol HLE per cm2 skin, the range
between 0.5 fmol and 40 pmol HLE per cm2 skin. The high
variation reflects the variability of the neutrophil infiltrate in
psoriatic lesions. Elastase might be an important stimulus
for epidermal proliferation in early stage psoriasis as HLE
was detected predominantly in acute lesions (Glinski et al,
1984). It is believed that psoriatic lesions enlarge by
centrifugal expansion (Ragaz and Ackerman, 1979; Gerrit-
sen et al, 1997). The margin of spreading plaques
represents the most active site, as indicated by a higher
density of spongiform pustules of Kogoj and microabs-
cesses of Munro (Beurskens et al, 1989; van de Kerkhof and
Chang, 1989). Studies which demonstrated that elafin is
increased within the psoriatic plaque (Schalkwijk et al, 1993)
and significantly more in the region of the center than in the
margin (van de Kerkhof et al, 1991) provide evidence that
elastase activation may also be a crucial factor for the
enlargement of psoriatic plaques.
Neutrophil recruitment normally provides protective
effects of the host against skin infection. It assists in the
entrapment and clearance of potentially invasive micro-
organisms and induces keratinocyte proliferation. However,
in pathological states like psoriasis and other chronic
inflammatory disorders of the skin, epidermal hyperproli-
feration is a typical pathological finding. This study shows
for the first time that a proteolytic action of HLE induces
keratinocyte proliferation via an EGFR signaling pathway.
The results suggest that cleavage of the EGFR ligand TGF-a
and its subsequent activation of EGFR are involved in this
response. This might explain at least in part the epidermal
hyperproliferation seen in psoriasis. Our findings demon-
strate a novel mechanism in keratinocyte proliferation and
suggest novel strategies for therapeutic intervention.
Materials and Methods
Materials HLE (EC 3.4.21.37) was obtained from Elastin Products
(Owensville, Missouri). Active sites were titrated with recombinant
eglin C (Ciba Geigy, Basel, Switzerland). HLE proved to be more
than 80% catalytically active. HLE was dissolved in 0.1 M sodium
acetate (pH 5.0) and diluted with Hank’s buffered saline solution
(HBSS) immediately before application. Proteolytic activity was
measured after each experiment by substrate assay with MeoSuc-
Ala-Ala-Pro-Val-p-nitroanilide (Sigma-Aldrich, Munich, Germany).
The synthetic PAR2 activating peptide SFLLRN, synthesized by
Prof. H. Kalbacher (Tu¨bingen, Germany), was dissolved in distilled
water and stored at 201C until usage. Neutralizing antibodies
against EGFR (Ab.-1) and TGF-a (Ab.-3) were purchased from
Calbiochem (Darmstadt, Germany). According to the manufacturer
EGFR antibody exhibits no cross-reactivity against other receptors
and binds to the extracellular part of EGFR. The TGF-a antibody
shows no cross-reactivity against other EGFR ligands according to
Calbiochem. Recombinant human TGF-a and EGF as well as
genistein and myristoylated EGFR fragment (651–658) were
purchased from Calbiochem. Recombinant 57 amino acid length
elafin was a kind donation from Proteo Biotech AG (Kiel, Germany)
and recombinant human SLPI(antileukoprotease) was a gift from
Gru¨nenthal GmbH (Aachen, Germany). Trypsin (EC 3.4.21.4,
Sigma-Aldrich) was dissolved in 1 mM HCl (pH 5.0) and diluted
with HBSS immediately before application.
Culture of human keratinocytes The spontaneously immorta-
lized human keratinocyte cell line HaCaT (Prof. N. Fusenig, German
Cancer Research Center, Heidelberg, Germany) was cultured in
Dulbecco’s modified Eagle’s medium (DMEM) (GIBCO BRL,
Rockville, Maryland) supplemented with 10% fetal calf serum
(FCS), l-glutamine (2 mM), and antibiotics (100 U per mL penicillin
and 100 U per mL streptomycin) and incubated at 371C in 5% CO2
humid atmosphere. Human keratinocytes were isolated from
neonatal foreskin and cultured in Epilife Medium (Sigma-Aldrich)
also at 371C in 5% CO2 humid atmosphere.
Calcium inﬂux Cells were seeded on a collagen pre-coated
sterile chambered slide system (Nunc, Roskilde, Denmark) and
incubated in DMEM medium at 371C in 5% CO2 in humid
atmosphere. Cells were incubated with 5 mM FURA2AM (Calbio-
chem) dissolved in DMEM medium for 1 h. The medium was
replaced by HBSS containing 1.5 mmol per liter calcium dichloride
and magnesium dichloride. Slides with FURA2-loaded HaCaT
keratinocytes were placed on the stage of an inverted fluorescence
microscope (Olympus, Hamburg, Germany) at room temperature.
The excitation wavelength was altered between 340 and 380 nm
by a dual wavelength monochromator. An intensified CCD camera
(TILL Photonics, Mu¨nchen, Germany) was used to acquire real-
time images. The ratio of the fluorescence at the two excitation
wavelengths was calculated, which is proportional to the [Ca2þ ]i.
The number of cells was counted and percentage of responding
cells was calculated.
Keratinocyte proliferation assay Proliferation of cultured cells
was assessed by BrdU-labeling method (Porstmann et al, 1985) for
measuring DNA synthesis. HaCaT keratinocytes were plated in 96-
well flat-bottomed microtiter plates at a density of 5000 cells per
well and cultured overnight in DMEM medium without FCS. Cells
were washed twice with phosphate-buffered saline (PBS) and the
medium was replaced with DMEM without FCS supplemented with
HLE in various concentrations in the presence of 100 mM BrdU for
20 h, with or without neutralizing antibodies against TGF-a or
EGFR and 40 ng per mL recombinant human EGF as a positive
control. Incorporation of BrdU was determined using a cell
proliferating enzyme-linked immunosorbent assay (Proliferation
ELISA, Roche, Mannheim, Germany) according to the instructions
of the manufacturer. The absorbance was measured using a
spectrophotometer at 450 versus 620 nm. Absorbance was
corrected to the measured absorbance of buffer-control and
related to unstimulated cells. Statistical analysis was performed
by unpaired t test comparison, with a p-value of o0.001 being set
a priori as the level sought for statistical significance.
We thank Mrs N. Linke for technical assistance and J.-M. Schro¨der for
helpful discussion. This research was supported by a grant of the
Mukoviszidose e.V. and the Deutsche Forschungsgemeinschaft SFB-
617.
344 MEYER-HOFFERT ET AL THE JOURNAL OF INVESTIGATIVE DERMATOLOGY
DOI: 10.1111/j.0022-202X.2004.23202.x
Manuscript received July 14, 2003; revised November 6, 2003;
accepted for publication November 25, 2003
Address correspondence to: Oliver Wiedow, Department of Dermatol-
ogy, University Kiel, Schittenhelmstr. 7, D-24105 Kiel, Germany. Email:
owiedow@dermatology.uni-kiel.de
References
Belham CM., Tate RJ, Scott PH, et al: Trypsin stimulates proteinase-activated
receptor-2-dependent and -independent activation of mitogen-activated
protein kinases. Biochem J 320 (Part 3):939–946, 1996
Beurskens T, Chang A, van Erp PE, van de Kerkhof PC: Epidermal proliferation
and accumulation of polymorphonuclear leukocytes in the psoriatic
lesion. Dermatologica 178:67–72, 1989
Brachmann R, Lindquist PB, Nagashima M, Kohr W, Lipari T, Napier M, Derynck
R: Transmembrane TGF-alpha precursors activate EGF/TGF-alpha
receptors. Cell 56:691–700, 1989
Cappelluti E, Strom SC, Harris RB: Potential role of two novel elastase-like
enzymes in processing pro-transforming growth factor-alpha. Biochem-
istry 32:551–560, 1993
Coffey RJ Jr, Derynck R, Wilcox JN, Bringman TS, Goustin AS, Moses HL,
Pittelkow MR: Production and auto-induction of transforming growth
factor-alpha in human keratinocytes. Nature 328:817–820, 1987
Cook PW, Mattox PA, Keeble WW, et al: A heparin sulfate-regulated human
keratinocyte autocrine factor is similar or identical to amphiregulin. Mol
Cell Biol 11:2547–2557, 1991
Cumashi A, Ansuini H, Celli N, De Blasi A, O’Brien PJ, Brass LF, Molino M: Neutrophil
proteases can inactivate human PAR3 and abolish the co- receptor function
of PAR3 on murine platelets. Thromb Haemost 85:533–538, 2001
Derian CK, Eckardt AJ, Andrade-Gordon P: Differential regulation of human
keratinocyte growth and differentiation by a novel family of protease-
activated receptors. Cell Growth Differ 8:743–749, 1997
Dery O, Corvera CU, Steinhoff M, Bunnett NW: Proteinase-activated receptors:
Novel mechanisms of signaling by serine proteases. Am J Physiol
274:C1429–C1452, 1998
Derynck R, Roberts AB, Winkler ME, Chen EY, Goeddel DV: Human transforming
growth factor-alpha: precursor structure and expression in E. coli. Cell
38:287–297, 1984
Dlugosz AA, Cheng C, Williams EK, et al: Autocrine transforming growth factor
alpha is dispensible for v-rasHa-induced epidermal neoplasia: Potential
involvement of alternate epidermal growth factor receptor ligands.
Cancer Res 55:1883–1893, 1995
Elder JT, Fisher GJ, Lindquist PB, et al: Overexpression of transforming growth
factor alpha in psoriatic epidermis. Science 243:811–814, 1989
Game SM, Huelsen A, Patel V, et al: Progressive abrogation of TGF-beta 1 and
EGF growth control is associated with tumour progression in ras-
transfected human keratinocytes. Int J Cancer 52:461–470, 1992
Gerritsen MJ, Elbers ME, de Jong EM, Van de Kerkhof PC: Recruitment of cycling
epidermal cells and expression of filaggrin, involucrin and tenascin in the
margin of the active psoriatic plaque, in the uninvolved skin of psoriatic
patients and in the normal healthy skin. J Dermatol Sci 14:179–188, 1997
Gill GN, Kawamoto T, Cochet C, et al: Monoclonal anti-epidermal growth factor
receptor antibodies which are inhibitors of epidermal growth factor
binding and antagonists of epidermal growth factor binding and
antagonists of epidermal growth factor-stimulated tyrosine protein kinase
activity. J Biol Chem 259:7755–7760, 1984
Glinski W, Barszcz D, Janczura E, Zarebska Z, Jablonska S: Neutral proteinases
and other neutrophil enzymes in psoriasis, and their relation to disease
activity. Br J Dermatol 111:147–154, 1984
Harris RC, Chung E, Coffey RJ: EGF receptor ligands. Exp Cell Res 284:2–13, 2003
Hashimoto K, Higashiyama S, Asada H, et al: Heparin-binding epidermal growth
factor-like growth factor is an autocrine growth factor for human
keratinocytes. J Biol Chem 269:20060–20066, 1994
Honegger AM, Szapary D, Schmidt A, et al: A mutant epidermal growth factor
receptor with defective protein tyrosine kinase is unable to stimulate
proto-oncogene expression and DNA synthesis. Mol Cell Biol 7:4568–
4571, 1987
Kawamoto T, Sato JD, Le A, Polikoff J, Sato GH, Mendelsohn J: Growth
stimulation of A431 cells by epidermal growth factor: Identification
of high-affinity receptors for epidermal growth factor by an anti-
receptor monoclonal antibody. Proc Natl Acad Sci USA 80:1337–1341,
1983
King LE Jr, Gates RE, Stoscheck CM, Nanney LB: The EGF/TGF alpha receptor in
skin. J Invest Dermatol 94:164S–170S, 1990
Kohri K, Ueki IF, Nadel JA: Neutrophil elastase induces mucin production by
ligand-dependent epidermal growth factor receptor activation. Am J
Physiol Lung Cell Mol Physiol 283:L531–L540, 2002
Lee DC, Fenton SE, Berkowitz EA, Hissong MA: Transforming growth factor
alpha: Expression, regulation, and biological activities. Pharmacol Rev
47:51–85, 1995
Loew D, Perrault C, Morales M, et al: Proteolysis of the exodomain of
recombinant protease-activated receptors: Prediction of receptor acti-
vation or inactivation by MALDI mass spectrometry. Biochemistry
39:10812–10822, 2000
Maas-Szabowski N, Starker A, Fusenig NE: Epidermal tissue regeneration and
stromal interaction in HaCaT cells is initiated by TGF-alpha. J Cell Sci
116:2937–2948, 2003
Mueller SG, Paterson AJ, Kudlow JE: Transforming growth factor alpha in
arterioles: Cell surface processing of its precursor by elastases. Mol Cell
Biol 10:4596–4602, 1990
Pandiella A, Massague J: Cleavage of the membrane precursor for transforming
growth factor alpha is a regulated process. Proc Natl Acad Sci USA
88:1726–1730, 1991
Porstmann T, Ternynck T, Avrameas S: Quantitation of 5-bromo-2-deoxyuridine
incorporation into DNA: An enzyme immunoassay for the assessment of
the lymphoid cell proliferative response. J Immunol Methods 82:169–179,
1985
Ragaz A, Ackerman AB: Evolution, maturation, and regression of lesions of
psoriasis. New observations and correlation of clinical and histologic
findings. Am J Dermatopathol 1:199–214, 1979
Rogalski C, Meyer-Hoffert U, Proksch E, Wiedow O: Human leukocyte elastase
induces keratinocyte proliferation in vitro and in vivo. J Invest Dermatol
118:49–54, 2002
Schalkwijk J, van Vlijmen IM, Alkemade JA, de Jongh GJ: Immunohistochemical
localization of SKALP/elafin in psoriatic epidermis. J Invest Dermatol
100:390–393, 1993
Schlessinger J: Cell signaling by receptor tyrosine kinases. Cell 103:211–225,
2000
Shirakata Y, Komurasaki T, Toyoda H, et al: Epiregulin, a novel member of the
epidermal growth factor family, is an autocrine growth factor in normal
human keratinocytes. J Biol Chem 275:5748–5753, 2000
Strachan L, Murison JG, Prestidge RL, Sleeman MA, Watson JD, Kumble KD:
Cloning and biological activity of epigen, a novel member of the
epidermal growth factor superfamily. J Biol Chem 276:18265–18271,
2001
Teixido J, Wong ST, Lee DC, Massague J: Generation of transforming growth
factor-alpha from the cell surface by an O-glycosylation-independent
multistep process. J Biol Chem 265:6410–6415, 1990
van de Kerkhof PC, Chang A: Migration of polymorphonuclear leukocytes in
psoriasis. Skin Pharmacol 2:138–154, 1989
van de Kerkhof PC, Kuppens LH, Van Vlijmen Y, Schalkwijk J: Distribution of skin-
derived antileucoproteases (SKALP) in the marginal zone of the spreading
psoriatic lesion. Br J Dermatol 124:10–12, 1991
Wiedow O, Wiese F, Christophers E: Lesional elastase activity in psoriasis.
Diagnostic and prognostic significance. Arch Dermatol Res 287:632–635,
1995
Wiedow O, Wiese F, Streit V, Kalm C, Christophers E: Lesional elastase activity in
psoriasis, contact dermatitis, and atopic dermatitis. J Invest Dermatol
99:306–309, 1992
Yu Z, Ahmad S, Schwartz JL, Banville D, Shen SH: Protein-tyrosine phosphatase
SHP2 is positively linked to proteinase- activated receptor 2-mediated
mitogenic pathway. J Biol Chem 272:7519–7524, 1997
ELASTASE INDUCES EGFR ACTIVATION 345123 : 2 AUGUST 2004
